Cite

HARVARD Citation

    Bhangoo, M. et al. (2019). Secondary malignancies after treatment with single-agent vemurafenib in two patients with refractory hairy cell leukemia. Leukemia & lymphoma. 60 (5), pp. 1331-1333. [Online]. 
  
Back to record